Sarah Nemec is Senior VP, Finance and PAO of Bolt Biotherapeutics, Inc.. Currently has a direct ownership of 23,943 shares of BOLT, which is worth approximately $107,743. The most recent transaction as insider was on Oct 22, 2025, when has been sold 23,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K
2439.02% 3M change
43.95% 12M change
Total Value Held $107,743

Sarah Nemec Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2025
BUY
Grant, award, or other acquisition
-
23,000 Added 49.0%
23,943 Common Stock
Jun 06 2025
BUY
Open market or private purchase
$686 $5.49 p/Share
125 Added 11.7%
943 Common Stock
Dec 16 2024
BUY
Open market or private purchase
$1,250 $0.5 p/Share
2,500 Added 13.07%
16,633 Common Stock
Jun 06 2024
BUY
Open market or private purchase
$1,600 $0.64 p/Share
2,500 Added 15.28%
13,863 Common Stock
SN

Sarah Nemec

Senior VP, Finance and PAO
Redwood City, CA

Track Institutional and Insider Activities on BOLT

Follow Bolt Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BOLT shares.

Notify only if

Insider Trading

Get notified when an Bolt Biotherapeutics, Inc. insider buys or sells BOLT shares.

Notify only if

News

Receive news related to Bolt Biotherapeutics, Inc.

Track Activities on BOLT